.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Deloitte
AstraZeneca
Accenture
Argus Health
Queensland Health
Teva
Julphar
Cipla
Johnson and Johnson

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for Biologics License Application 103979

« Back to Dashboard

Summary for BLA: 103979

Tradename:
FABRAZYME
Applicant:
Genzyme
Ingredient:
agalsidase beta
Patents:9
Approval Date:Apr 24, 2003
Suppliers: see list1

Pharmacology for BLA: 103979

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Genzyme
FABRAZYME
agalsidase beta
VIAL; INTRAVENOUS1039790012003-04-245,356,804 Mount Sinai School of Medicine of the City of New York (New York, NY) Desnick; Robert J. (New York, NY), Bishop; David F. (New York, NY), Ioannou; Yiannis A. (New York, NY) ► SubscribeRXOrphancompany
Genzyme
FABRAZYME
agalsidase beta
VIAL; INTRAVENOUS1039790022003-04-245,356,804 Mount Sinai School of Medicine of the City of New York (New York, NY) Desnick; Robert J. (New York, NY), Bishop; David F. (New York, NY), Ioannou; Yiannis A. (New York, NY) ► SubscribeRXOrphancompany
Genzyme
FABRAZYME
agalsidase beta
VIAL; INTRAVENOUS1039790012003-04-247,560,444 Momenta Pharmaceuticals, Inc. (Cambridge, MA) Richardson; Thomas (South Boston, MA), Venkataraman; Ganesh (Bedford, MA), Qi; Yiwei (Andover, MA), Picard; Michele (Dover, MA) ► SubscribeRXOrphansearch
Genzyme
FABRAZYME
agalsidase beta
VIAL; INTRAVENOUS1039790022003-04-247,560,444 Momenta Pharmaceuticals, Inc. (Cambridge, MA) Richardson; Thomas (South Boston, MA), Venkataraman; Ganesh (Bedford, MA), Qi; Yiwei (Andover, MA), Picard; Michele (Dover, MA) ► SubscribeRXOrphansearch
Genzyme
FABRAZYME
agalsidase beta
VIAL; INTRAVENOUS1039790012003-04-248,748,577 Cell Therapeutics, Inc. (Seattle, WA) Besman; Marc (Seattle, WA), Chipman; Stewart (Bainbridge Island, WA), Leung; David (Mercer Island, WA), Singer; Jack (Seattle, WA) ► SubscribeRXOrphansearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Teva
Medtronic
Merck
Covington
AstraZeneca
Fish and Richardson
McKinsey
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot